Breaking News
Get 40% Off 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

Alibaba Health Information Technology Ltd (0241)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
2.61 -0.04    -1.51%
09:08:33 - Closed. Currency in HKD ( Disclaimer )
  • Volume: 35,695,218
  • Bid/Ask: 2.61 / 2.62
  • Day's Range: 2.59 - 2.66
Type:  Equity
Market:  Hong Kong
ISIN:  BMG0171K1018 
Alibaba Health Information Tech 2.61 -0.04 -1.51%

HK:0241 Financials

 
This summary provides an overview of the most significant critical numbers from each of the Alibaba Health Information Technology Ltd financial reports, including theAlibaba Health Information Technology Ltd income statement, balance sheet, and cash flow statement. Additionally, it features several financial ratios that provide insight into the company's financial health.

Investors can select to view data from four periods of either annual or quarterly information, allowing them to track the HK:0241 financials over time via breakdowns of their annual reports.

Alibaba Health Information Technology Limited reported earnings results for the half year ended September 30, 2023. For the half year, the company reported sales was CNY 12,956 million compared to CNY 11,500.57 million a year ago. Net income was CNY 445.89 million compared to CNY 162.19 million a year ago. Basic earnings per share from continuing operations was CNY 0.033 compared to CNY 0.012 a year ago. Diluted earnings per share from continuing operations was CNY 0.0329 compared to CNY 0.012 a year ago.

AnnualQuarterly  
InvestingPro Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

0241 Income Statement & Profits

Gross margin TTM 22.22%
Operating margin TTM 0.87%
Net Profit margin TTM 2.9%
Return on Investment TTM 1.44%
 Total Revenue  Net Income
Period Ending: Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022
Total Revenue 6478 6478 7631.22 7631.22
Gross Profit 1434.33 1434.33 1700.34 1700.34
Operating Income 130.04 130.04 17.3 17.3
Net Income 222.95 222.95 186.37 186.37

0241 Balance Sheet

Quick Ratio MRQ 2.44
Current Ratio MRQ 3.01
LT Debt to Equity MRQ -
Total Debt to Equity MRQ 0.55%
 Total Assets  Total Liabilities
Period Ending: Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022
Total Assets 21439.69 21439.69 20747.56 20747.56
Total Liabilities 5377.93 5377.93 5600.22 5600.22
Total Equity 16061.76 16061.76 15147.33 15147.33

%ENGLISH_NAME% Latest Cash Flow Statement

Cash Flow/Share TTM 0.05
Revenue/Share TTM 2.09
Operating Cash Flow  8.74%
 Cash  Net Change in Cash
Period Ending: Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022
Period Length: 0 Months 0 Months 0 Months 0 Months
Cash From Operating Activities 455.09 455.09 -124.18 -124.18
Cash From Investing Activities -489.7 -489.7 102.06 102.06
Cash From Financing Activities -15.06 -15.06 -47.63 -47.63
Net Change in Cash 41.92 41.92 -82.99 -82.99
* In Millions of CNY (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

0241 Price Commentary

Write your thoughts about Alibaba Health Information Technology Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Grace Obeng
Grace Obeng Sep 10, 2021 19:58
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Yes
Goh David
Goh David Jun 04, 2021 3:09
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Alibaba Health should head back to $21.50 before testing higher at $24-25
Goh David
Goh David Jun 04, 2021 3:03
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Alibaba Health should head back to $21.50 before testing higher at $24-25
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email